Bioinformatics

#AI / data analytics / healthtech / informatics #Bioinformatics #Drug discovery #Genomics #QUIAGEN

QIAGEN expands AI-powered bioinformatics for research and drug discovery   

QIAGEN’s new artificial intelligence (AI) capabilities will reportedly help researchers analyse complex biological and genomic data faster while keeping the scientific evidence behind the results visible.  The expansion includes IPA Investigator, a new AI research companion for QIAGEN Ingenuity Pathway Analysis (IPA), and the new QIAGEN Discovery… Read More

#News

#Bioinformatics #Enedra Therapeutics #Funding #Oncology #Precision medicine #Start-ups

Enedra secures financing for precision cancer therapies

Enedra Therapeutics has secured venture financing and non-dilutive funding through UKRI’s Innovate UK Future Economy Investor Partnerships programme to support the development of next-generation precision therapies for advanced, genetically heterogeneous cancers.  The financing round was supported by KU Leuven’s Centre for Drug Design and Discovery (CD3), o2h… Read More

#Business & Investment #News #Start-up Zone

#AI / data analytics / healthtech / informatics #American Chemical Society #Bioinformatics #Drug discovery

CAS BioFinder Discovery Platform offers drug discovery insights

CAS, a division of the American Chemical Society, has launched the CAS BioFinder Discovery Platform, designed to reveal novel drug discovery insights through data connections. The offering provides drug discovery scientists with the ability to explore known and predicted data, find answers to their questions, and… Read More

#News

Big genomic data
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Bioinformatics #Collaboration #Genetics / genomics #Oncology #Partnership

Partners hope to “chart a new era of drug discovery”

A new multi-year strategic partnership between M2GEN and Zephyr AI will leverage clinicogenomic data, bioinformatics, and artificial intelligence to accelerate drug discovery and expanded use cases for oncology treatments.  In this partnership, M2GEN will license its real-world data set (RWD) to Zephyr AI, while Zephyr AI will… Read More

#Cancer Research #News

#AI / data analytics / healthtech / informatics #Bioinformatics #Drug development #Drug discovery #Emmes #Omics #Personalised medicine #Systems biology

How big data analytics can make personalised care a reality

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. A key breakthrough area where big data analytics has shown tremendous scope and application is… Read More

#Exclusive Content #Opinion

Microbiome
#Bioinformatics #Gut microbiome #Mergers and acquisitions #Metabolomics #Microbiome

Acquisition will “integrate microbiome and metabolome data”

Microbiome research company Clinical Microbiomics has acquired MS-Omics, a leading provider based in Denmark.   With this acquisition, Clinical Microbiomics hopes to further advance its systems biology platform and help researchers worldwide understand the microbiome and how to impact health and disease.    Anders Grøn,… Read More

#Business & Investment #News

#AI / data analytics / healthtech / informatics #Bioinformatics #Biopharmaceuticals #Biotechnology #Collaboration

Scitara joins collaboration to drive biopharmaceutical advancements  

Scitara has become a member of BioPhorum, a global community that enables collaboration throughout the biopharmaceutical industry with the goal of accelerating scientific advancements.  The Lab of the Future  Scitara joins BioPhorum Information Technology, which aims to accelerate digital maturity across the global biomanufacturing industry. One of the programmes within the portfolio,… Read More

#News

#Bioinformatics #Data #Life sciences

Pluto Biosciences launches collaborative life sciences platform 

Pluto Biosciences has launched a cloud-based, collaborative life sciences platform that leverages technology developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University. The Pluto platform simplifies secure, collaborative data sharing and bioinformatics analysis for academic, biotech, and pharmaceutical organisations.   The Pluto platform was built to… Read More

#News

#Bioinformatics #Biomedical research #Neurodegenerative disorders #Neuroscience #Research

Novel research identifies gene targets of stress hormones in the brain

New research has moved a step forward in understanding how glucocorticoid hormones (‘stress hormones’) act upon the brain and what their function is. The findings could lead to more effective strategies in the prevention and treatment of mental health disorders. The study, led by academics at the University of Bristol… Read More

#News #Trending News

#Bioinformatics #Biotechnology #Informatics #Pharmaceutical research

PerkinElmer expands informatics capabilities in biologics drug discovery

Biotechnology company PerkinElmer has announced its documentation, workflow and decision-making informatics platform, Signals, is expanding to build on existing capabilities in the biologics drug discovery space. This comes through a collaboration with Insightful Science, a software company serving the global life sciences community. With the collaboration, pharmaceutical and academic research… Read More

#News

#Bioinformatics #Informatics #Pharmaceutical #Phosphoproteomic

Is this start-up a game changer for drug discovery?  

Jane Theaker, Kinomica explains why she was so impressed with the preclinical datasets predicting for drug response that the company could produce, she decided to join as CEO. Kinomica is a spin out offering phosphoproteomic analyses to the pharmaceutical industry. Theaker has R&D expertise in novel diagnostic technologies. Her experience… Read More

#News #Start-up Zone